Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
AT
AKI Therapeutics A/S
aktivCVR 37509736AktieselskabSlotsmarken 12, 1 th, 2970 HørsholmFremstilling af farmaceutiske præparater
- Latest accounts
- 2024
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2024
Revenue
DKK 0
Latest period
Source details
Source: dk-regnskabsdata-live-37509736-1793929115572
Document: dk-regnskabsdata-37509736-AZgNxe-mhegZy6r8J_xj-1
XBRL: ifrs-full:Revenue
Period: 01 Jan 2024 - 31 Dec 2024
Technical details
Context: ctx1
Unit: vDKK
Operating profit
DKK -1.9m
Latest period
Source details
Source: dk-regnskabsdata-live-37509736-1793929115572
Document: dk-regnskabsdata-37509736-AZgNxe-mhegZy6r8J_xj-1
XBRL: ifrs-full:ProfitLossFromOperatingActivities
Period: 01 Jan 2024 - 31 Dec 2024
Technical details
Context: ctx1
Unit: vDKK
Net result
DKK -2m
Latest period
Source details
Source: dk-regnskabsdata-live-37509736-1793929115572
Document: dk-regnskabsdata-37509736-AZgNxe-mhegZy6r8J_xj-1
XBRL: ifrs-full:ProfitLoss
Period: 01 Jan 2024 - 31 Dec 2024
Technical details
Context: ctx1
Unit: vDKK
Equity
DKK 806.8k
Equity ratio: 37.2%
Source details
Source: dk-regnskabsdata-live-37509736-1793929115572
Document: dk-regnskabsdata-37509736-AZgNxe-mhegZy6r8J_xj-1
XBRL: ifrs-full:Equity
Period: 01 Jan 2024 - 31 Dec 2024
Technical details
Context: ctx8
Unit: vDKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | DKK 0 | DKK -1.1m |
| 2023 | DKK 0 | DKK -1.7m |
| 2024 | DKK 0 | DKK -2m |